Biolase
(NASDAQ:BIOL)
$0.18
-0.0111[-5.81%]
At close: Mar 28
$0.18
0[0.00%]
After Hours: 7:59PM EDT
Consensus Rating1
Buy
Highest Price Target1
$12.00
Lowest Price Target1
$0.40
Consensus Price Target1
$3.45

Biolase Stock (NASDAQ:BIOL), Analyst Ratings, Price Targets, Predictions

Biolase Inc has a consensus price target of $3.45, established from looking at the 6 latest analyst ratings. The last 3 analyst ratings were released from Benchmark, Lake Street, and Maxim Group on March 22, 2024, May 31, 2023, and March 29, 2023. With an average price target of $0.6 between Benchmark, Lake Street, and Maxim Group, there's an implied 233.33% upside for Biolase Inc from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Mar
0
0
0
0
0
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Benchmark
Lake Street
Maxim Group
Lake Street

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Biolase

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
03/22/2024BIOLBuy Now
Biolase
$0.18122.22%Benchmark
Bruce Jackson
$2.5 → $0.4MaintainsSpeculative BuyGet Alert
05/31/2023BIOLBuy Now
Biolase
$0.18122.22%Lake Street
Frank Takkinen
$150 → $40MaintainsBuyGet Alert
03/29/2023BIOLBuy Now
Biolase
$0.18455.56%Maxim Group
Anthony Vendetti
$500 → $100MaintainsBuyGet Alert
03/29/2023BIOLBuy Now
Biolase
$0.181011.11%Benchmark
Bruce Jackson
→ $200Reiterates → Speculative BuyGet Alert
01/20/2023BIOLBuy Now
Biolase
$0.18733.33%Lake Street
Frank Takkinen
→ $150Assumes → BuyGet Alert
05/20/2022BIOLBuy Now
Biolase
$0.186566.67%Lake Street
Kyle Bauser
→ $1200Initiates → BuyGet Alert

FAQ

Q

What is the target price for Biolase (BIOL)?

A

The latest price target for Biolase (NASDAQ: BIOL) was reported by Benchmark on March 22, 2024. The analyst firm set a price target for $0.40 expecting BIOL to rise to within 12 months (a possible 122.22% upside). 2 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Biolase (BIOL)?

A

The latest analyst rating for Biolase (NASDAQ: BIOL) was provided by Benchmark, and Biolase maintained their speculative buy rating.

Q

When was the last upgrade for Biolase (BIOL)?

A

There is no last upgrade for Biolase.

Q

When was the last downgrade for Biolase (BIOL)?

A

There is no last downgrade for Biolase.

Q

When is the next analyst rating going to be posted or updated for Biolase (BIOL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biolase, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biolase was filed on March 22, 2024 so you should expect the next rating to be made available sometime around March 22, 2025.

Q

Is the Analyst Rating Biolase (BIOL) correct?

A

While ratings are subjective and will change, the latest Biolase (BIOL) rating was a maintained with a price target of $2.50 to $0.40. The current price Biolase (BIOL) is trading at is $0.18, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch